SCHEMBL276423

SCHEMBL276423

COC(=O)C(Cl)C(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 3/20 0.56
▸ GAA P10253 3/20 0.56
▸ HSP90AA1 P07900 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ KMT2A Q03164 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.50
▸ GPR55 Q9Y2T6 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ PTGS1 P23219 1/20 0.45
▸ PTGS2 P35354 1/20 0.45
▸ TDP1 Q9NUW8 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CYP3A4 P08684 1/20 0.43
▸ CES2 O00748 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CES1 P23141 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9132366 0.90 PDCD1 (0.47) ATMGAAHSP90AA1NPC1RAB9A
SCHEMBL9431238 0.83 MEN1 (0.49) ATMGAAKMT2AALDH1A1GPR55
SCHEMBL13513405 0.81 NPC1 (0.56) ATMGAAHSP90AA1NPC1RAB9A
SCHEMBL670205 0.81 NPC1 (0.56) ATMGAAHSP90AA1NPC1RAB9A
SCHEMBL9187295 0.81 CA1 (0.53) GAANPC1RAB9AALDH1A1CES2
SCHEMBL1533349 0.81 RAB9A (0.44) ATMGAANPC1RAB9AKMT2A
SCHEMBL23931566 0.81 SLC6A2 (0.57) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL30012030 0.81 SLC6A2 (0.57) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL28677091 0.81 CES2 (0.50) GAANPC1RAB9AKMT2AALDH1A1
SCHEMBL2358014 0.81 ATM (0.64) ATMGAAHSP90AA1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121824461-A Method for preparing dihydrofuran-containing compound by utilizing alpha-halogenated ester 扬州大学 2026-04-10 — — CN disclosed
US-11339130-B1 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2022-05-24 — — US disclosed
US-10934261-B2 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2021-03-02 — — US disclosed
US-10894776-B2 — — 2021-01-19 — — US disclosed
US-20180125848-A1 PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS VIBLIOME THERAPEUTICS, LLC 2018-05-10 — — US disclosed
US-9833455-B2 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors SPACEFILL ENTERPRISES LLC (US) 2017-12-05 — — US disclosed
CN-103449946-B Preparation method of alpha-monochlorinated ketone compound UNIV HUANGSHAN 2015-01-14 — — CN disclosed
CN-103449946-A Preparation method of alpha-monochlorinated ketone compound UNIV HUANGSHAN 2013-12-18 — — CN disclosed
US-8133901-B2 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors ACTELION PHARMACEUTICALS LTD. (CH) 2012-03-13 — — US disclosed
US-7994336-B2 Azetidine compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2011-08-09 — — US disclosed
US-20100222600-A1 AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2010-09-02 — — US disclosed
US-20100069418-A1 3-HETEROARYL (AMINO OR AMIDO)-1-(BIPHENYL OR PHENYLTHIAZOLYL) CARBONYLPIPERIDINE DERIVATIVES AS OREXIN RECEPTOR INHIBITORS ACTELION PHARMACEUTICALS LTD. (CH) 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180125848-A1 PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS ABL1, ERBB2, MAP3K2 ATM 431/4885GAA 1799/4885HSP90AA1 1362/4885
US-10934261-B2 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 ATM 2171/4885GAA 616/4885HSP90AA1 224/4885
US-10894776-B2 — CAPNS1, CAPN9, CAPN2 ATM 1783/4885GAA 751/4885HSP90AA1 264/4885
US-20100222600-A1 AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, NPY1R ATM 4817/4885GAA 2145/4885HSP90AA1 4239/4885
US-11339130-B1 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 ATM 2171/4885GAA 616/4885HSP90AA1 224/4885
US-20100069418-A1 3-HETEROARYL (AMINO OR AMIDO)-1-(BIPHENYL OR PHENYLTHIAZOLYL) CARBONYLPIPERIDINE DERIVATIVES AS OREXIN RECEPTOR INHIBITORS HCRTR1, HCRTR2, NPY1R ATM 4768/4885GAA 2954/4885HSP90AA1 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback